Lustgarten Foundation Appoints David Tuveson, M.D., Ph.D., Chief Scientist
Dr. David Tuveson has been appointed the chief scientist for the Lustgarten Foundation. He specializes in pancreatic cancer reseach at the Cold Spring Harbor Labs.
Dr. David Tuveson has been appointed the chief scientist for the Lustgarten Foundation. He specializes in pancreatic cancer reseach at the Cold Spring Harbor Labs.
Meet long-term survivors of pancreatic cancers, in our new Survivors Video Series. The introductory video was launched in January at a cancer symposium.
"Introduction of #PancChat: A novel Twitter platform to inform and engage the pancreatic cancer community" at the 2018 Gastrointestinal Cancers…
Dr. Anne Marie Lennon and colleagues have developed a blood screening test that can detect early cancer in eight organs, including the pancreas.
The Lustgarten Foundation shares the story that Keytruda (pembrolizumab) is a runner-up in Science magazine’s Breakthrough of the year.
The Lustgarten Foundation and Stand Up To Cancer announced the launch of two new pancreatic cancer interception research projects.
Dr. David Tuveson, MD, PhD, Director of the Lustgarten Foundation Pancreatic Research Laboratory at Cold Spring Harbor Laboratory, explains why pancreatic cancer is so difficult to treat.
On Thursday, September 14, Finn Partners announced that Let’s Win, an initiative supported by the Lustgarten Foundation, is being inducted…
The combination of ctDNA and protein markers was superior to any single marker alone. This work was funded in part…
The approach is called chimeric antigen receptor (CAR) T-cell therapy, which uses specially modified immune cells to find and destroy…